IMR Press / CEOG / Volume 35 / Issue 3 / pii/1630638715685-402194299

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
The effect of buserelin acetate on the uterus of adult rats: morphological aspects
Show Less
1 Department of Gynecology and Obstetrics, School of Medicine, School of Health Sciences, Espírito Santo
2 Department of Gynecology and Obstetrics, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais
3 Department of Pathology, School of Medicine, Federal University of Espírito Santo, Espírito Santo (Brazil)
Clin. Exp. Obstet. Gynecol. 2008, 35(3), 198–201;
Published: 10 September 2008
Abstract

Purpose of investigation: To evaluate the effect of buserelin acetate on the morphology of the endometrium of adult, non-castrated, female Wistar rats. Methods: Female Wistar rats at estrus or diestrus (assessed by vaginal cytology) received daily subcutaneous injections of 20 mg buserelin acetate for four, eight or 12 days. Rats were sacrificed 24 hours or five days following final dosage. A control group received diluent for 12 days. Results: Progressive tissue hypotrophy occurred during treatment and was followed by estrogenic hyperactivity five days after the end of treatment. Vaginal cytology and endometrial histology revealed intense, vacuolized lining and glandular epithelia, brush borders and endometrial stroma densely infiltrated with eosinophils. Conclusions: Buserelin acetate appears to cause a progressive blockade of gonadotrophin secretion when administered to female rats for four, eight or 12 days, and an important rebound effect, with accentuated estrogen release already apparent in the first estrous cycle following treatment.
Keywords
Buserelin
Gonadotrophin
Female rats
Estrous cycle
Cytology
Endometrium
Eosinophilia
Share
Back to top